Skip NavigationSkip to Content

Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: Balance between RNase H activity and nucleotide excision

  1. Author:
    Nikolenko, G. N.
    Palmer, S.
    Maldarelli, F.
    Mellors, J. W.
    Coffin, J. M.
    Pathak, V. K.
  2. Author Address

    NCI, HIV Drug Resistance Program, Viral Mutat Sect, Frederick, MD 21702 USA. NCI, HIV Drug Resistance Program, Host Virus Interact Unit, Frederick, MD 21702 USA. Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15260 USA Pathak, VK, NCI, HIV Drug Resistance Program, Viral Mutat Sect, Bldg 535,Room 334, Frederick, MD 21702 USA
    1. Year: 2005
    2. Date: FEB 8
  1. Journal: Proceedings of the National Academy of Sciences of the United States of America
    1. 102
    2. 6
    3. Pages: 2093-2098
  2. Type of Article: Article
  1. Abstract:

    Understanding the mechanisms of HIV-1 drug resistance is critical for developing more effective antiretroviral agents and therapies. Based on our previously described dynamic copy-choice mechanism for retroviral recombination and our observations that nucleciside reverse transcriptase inhibitors (NRTIs) increase the frequency of reverse transcriptase template switching, we propose that an equilibrium exists between (i) NRTI incorporation, NRTI excision, and resumption of DNA synthesis and (it) degradation of the RNA template by RNase H activity, leading to dissociation of the template-primer and abrogation of HIV-1 replication. As predicted by this model, mutations in the RNase H domain that reduced the rate of RNA degradation conferred high-level resistance to 3'-azido-3'-deoxythymidine and 2,3-didehydro-2,3-dideoxythymidine by as much as 180- and 10-fold, respectively, by increasing the time available for excision of incorporated NRTIs from terminated primers. These results provide insights into the mechanism by which NRTIs inhibit HIV-1 replication and imply that mutations in RNase H could significantly contribute to drug resistance either alone or in combination with NRTI-resistance mutations in reverse transcriptase

    See More

External Sources

  1. WOS: 000227072900053

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel